Skip to content

Clinical trials

Phase 1/2 trials in Australia with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 1/2 Status: Unknown status Country / region: Australia Clear all

33 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20065
20071
20081
20111
20131
20141
20151
20161
20171
20182
20193
20204
20215
20223
20232
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status33

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fermiscan Ltd2
Genor Biopharma Co., Ltd.2
Kartos Therapeutics, Inc.2
Minghui Pharmaceutical Pty Ltd2
Peter MacCallum Cancer Centre, Australia2
Ascentage Pharma Group Inc.1
Australasian Sarcoma Study Group1
Beijing InnoCare Pharma Tech Co., Ltd.1
BioSyngen Pte Ltd1
Central Adelaide Local Health Network Incorporated1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms3
Melanoma3
Carcinoma, Non-Small-Cell Lung2
Influenza, Human2
Leukemia, Myeloid, Acute2
Ocular Hypertension2
Alzheimer Disease1
Amyotrophic Lateral Sclerosis1
Burns1
Carcinoma, Hepatocellular1

Trials

Showing 1 to 25 of 33. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.